Study of Epratuzumab in Systemic Lupus Erythematosus

NCT00111306 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
510
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB Pharma